Notice on the 2026 Conference on Innovation and Development of Radiopharmaceuticals
Release time:
2026-07-03
The "2026 Conference on Innovation and Development of Radiopharmaceuticals," hosted by the Radiopharmaceutical Branch of the China Isotope and Radiation Industry Association, and co-organized by Nanolattix Biotechnology Co., Ltd., China National Nuclear Corporation (CNNC), the Chinese Institute of Radiation Protection, and Shanxi Medical University, is scheduled to be held in Taiyuan, Shanxi Province, from July 27 to 28, 2026.
Centered around the theme "Nuclear Synergy, Radiopharmaceutical Future," the conference will leverage Shanxi's strong foundation in the radiopharmaceutical industry to establish a high-end platform for exchange and collaborative innovation. Numerous academicians, experts, medical institutions, authoritative research institutes, and leading enterprises will gather in Longcheng (Taiyuan) to form an integrated industrial ecosystem covering the entire value chain—from medical isotope development and drug research to clinical diagnosis, radiation protection, and technology transfer—jointly shaping the strategic future of Shanxi’s radiopharmaceutical industry. As one of the co-organizers, Naaan will actively connect resources across government, industry, academia, research, and application sectors, empowering the construction of a radiopharmaceutical innovation cluster in Taiyuan and beyond, and driving regional industrial advancement toward higher quality and greater capabilities.
Tag:
recommend News
Share
